Item Brochure

Needle length (mm)
For a comfortable injection experience, shorter needle
lengths are recommended and preferred.
Needle gauge (G)
The higher the gauge, the thinner the needle.
For example, 32G is thinner than a 31G needle.
Insulin Syringe Volume (mL/cc):
BD – Your Diabetes Injection Experts
SM
The shortest, thinnest pen needle –
BD Nano 4mm x 32 G
BD Ultra-Fine
™
Pen Needles
BD Ultra-Fine
™
Nano 4 mm (5/32”) x 32 G
BD Ultra-Fine
™
Mini 5 mm (3/16”) x 31 G
BD Ultra-Fine
™
Short 8 mm (5/16”) x 31 G
BD Ultra-Fine
™
Original 12.7 mm (1/2”) x 29 G
The shortest, thinnest insulin syringe needle –
BD Ultra-Fine™ Needle
6mm (15/64”) x 31G
BD Insulin Syringes with the BD Ultra-Fine
™
Needle
BD Ultra-Fine
™
6mm 6 mm (15/64”) x 31 G
BD Ultra-Fine
™
Short 8 mm (5/16”) x 31 G
BD Ultra-Fine
™
12.7 mm (1/2”) x 30 G
(Actual Size)
BD Nano 4mm and BD Mini 5mm only available in pen needles.
6mm needle only available in syringes.
12.7 mm
(1/2”)
8 mm
(5/16”)
5 mm
(3/16”)
4 mm
(5/32”)
6 mm
(15/64”)
Capacity For doses up to:
3/10 mL (Half-Unit Scale) 30 units
3/10 mL 30 units
1/2 mL 50 units
1 mL 100 units
Why switch your patients
to a smaller needle?
Here are some important reasons to recommend the
new BD Insulin Syringe with the BD Ultra-Fine™ 6mm
needle and BD Ultra-Fine™ Nano 4mm x 32G
Pen Needle to your patients:
• Effective
As effective as longer needles.
1-3,5
• Less intimidating
• Reduces risk of a
painful injection
into the muscle
Shorter needles reduce
the risk of injecting into
the muscle.
4
Avoiding
injection into the muscle is
important for consistent absorption of insulin and
contributes to the management of blood glucose levels.
Proper Injection Technique
Proper injection technique is essential to improve
consistency in medication delivery and optimize
glycemic control.
1
It includes factors such as:
• knowing where the common injection sites are
• understanding how to rotate sites
• ensuring consistent delivery into subcutaneous
(fat) layer
• choosing proper needle length
• avoiding injecting into muscle
1. Schwartz S, Hassman D, Shelmet J, et al. A multicenter, open-label, randomized, two-period crossover trial
comparing glycemic control, satisfaction, and preference achieved with a 31 gauge x 6 mm needle versus a
29 gauge x 12.7 mm needle in obese patients with diabetes mellitus. Clin Ther. 2004;26(10):1663-1678. 2.
Kreugel G, Keers JC, Kerstens MN, Wolffenbuttel BHR. Randomized trial on the influence of the length of two
insulin pen needles on glycemic control and patient preference in obese patients with diabetes [published
online ahead of print April 10, 2011]. Diabetes Technol Ther. 2011;13(7):737-741. doi:10.1089/dia.2011.0010.
3. Hirsch LJ, Gibney MA, Albanese J, et al. Comparative glycemic control, safety and patient ratings for a new
4 mm x 32G insulin pen needle in adults with diabetes. Curr Med Res Opin. 2010;26(6)1531-1541. 4. Gibney
MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes
at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin.
2010;26(6):1519-1530. 5. In Pediatric and Adult patients (including obese patients). 6. Frid A, Hirsch L, Gaspar
R, et al. Special issue “New injection recommendations for patients with diabetes mellitus - Expert Consensus”
Diabetes Metab, 2010; 6 (suppl)
6
mm
TM
(Actual Size)
(Actual Size)
Not
Actual Size